In: Journal of Inherited Metabolic Disease, 2015, vol. 38, no. 6, p. 1007-1019
|
In: Journal of Inherited Metabolic Disease, 2015, vol. 38, no. 5, p. 957-967
|
In: PLOS genetics, 2019, vol. 15, no. 4, p. e1008069
In the peripheral nervous system (PNS) myelinating Schwann cells synthesize large amounts of myelin protein zero (P0) glycoprotein, an abundant component of peripheral nerve myelin. In humans, mutations in P0 cause the demyelinating Charcot-Marie-Tooth 1B (CMT1B) neuropathy, one of the most diffused genetic disorders of the PNS. We previously showed that several mutations, such as the...
|
In: Cancer Chemotherapy and Pharmacology, 2014, vol. 73, no. 6, p. 1181-1188
|
In: Cancer Causes & Control, 2012, vol. 23, no. 9, p. 1429-1442
|
In: Applied Microbiology and Biotechnology, 2005, vol. 68, no. 2, p. 228-236
|
In: Acta Neuropathologica, 2010, vol. 119, no. 5, p. 617-630
|
In: Journal of Inherited Metabolic Disease, 2013, vol. 36, no. 4, p. 595-612
|
In: Acta Neuropathologica, 2005, vol. 109, no. 1, p. 56-68
|
In: Journal of Clinical Immunology, 2010, vol. 30, p. 65-69
|